Fosfomycin--investigation of a possible new route of administration of an old drug. A case study

Michele Cree; Sonya Stacey; Nicolette Graham; Claire Wainwright

doi:10.1016/j.jcf.2006.08.003

Fosfomycin--investigation of a possible new route of administration of an old drug. A case study

J Cyst Fibros. 2007 May;6(3):244-6. doi: 10.1016/j.jcf.2006.08.003. Epub 2006 Oct 18.

Authors

Michele Cree¹, Sonya Stacey, Nicolette Graham, Claire Wainwright

Affiliation

¹ Pharmacy Department, Royal Children's Hospital, Brisbane, Australia. Michele_Cree@health.qld.gov.au

PMID: 17055346
DOI: 10.1016/j.jcf.2006.08.003

Abstract

Patients with cystic fibrosis can develop multi-resistant organisms and may have poor intravenous access making antibiotic treatment difficult. This case discusses the successful use of fosfomycin via the subcutaneous route in a paediatric patient with cystic fibrosis.

Publication types

Case Reports

MeSH terms

Adolescent
Anti-Bacterial Agents / administration & dosage*
Cystic Fibrosis / complications*
Cystic Fibrosis / microbiology
Drug Resistance, Multiple, Bacterial
Female
Fosfomycin / administration & dosage*
Humans
Injections, Subcutaneous
Pseudomonas Infections / drug therapy*
Pseudomonas Infections / etiology
Staphylococcal Infections / drug therapy*
Staphylococcal Infections / etiology

Substances

Anti-Bacterial Agents
Fosfomycin